Management of Venous Thromboembolism: Prophylaxis for Hospitalized and Non-Hospitalized Medical Patients
Publication Date: November 27, 2018
Recommendations
Acutely ill medical patients: pharmacological VTE prophylaxis
In acutely ill medical patients, the American Society of Hematology (ASH) guideline panel suggests using UFH, LMWH, or fondaparinux rather than no parenteral anticoagulant. (2, ⊕⊕oo)
312101
Among these anticoagulants, the panel suggests using LMWH (, ⊕⊕oo)
312101
- or fondaparinux
312101
- rather than UFH.
312101
Remark: These recommendations also apply to patients with stroke who receive VTE prophylaxis.
Critically ill medical patients: pharmacological VTE prophylaxis
In critically ill medical patients, the ASH guideline panel recommends using UFH or LMWH over no UFH or LMWH (1, ⊕⊕⊕o)
312101
and suggests using LMWH over UFH. (2, ⊕⊕⊕o)
312101
Acutely or critically ill medical patients: mechanical VTE prophylaxis vs a combination of pharmacological and mechanical or pharmacological VTE prophylaxis alone
In acutely or critically ill medical patients, the ASH guideline panel suggests using pharmacological VTE prophylaxis over mechanical VTE prophylaxis. (2, ⊕ooo)
312101
In acutely or critically ill medical patients who do not receive pharmacological VTE prophylaxis, the ASH guideline panel suggests using mechanical VTE prophylaxis over no VTE prophylaxis. (2, ⊕⊕⊕o)
312101
In acutely or critically ill medical patients, the ASH guideline panel suggests pharmacological or mechanical VTE prophylaxis alone over mechanical combined with pharmacological VTE prophylaxis. (2, ⊕ooo)
312101
In acutely or critically ill medical patients who are receiving mechanical VTE prophylaxis, the ASH guideline panel suggests using pneumatic compression devices or graduated compression stockings for VTE prophylaxis. (2, ⊕ooo)
312101
DOAC vs LMWH in acutely ill medical patients
In acutely ill hospitalized medical patients, the ASH guideline panel recommends using LMWH over DOACs for VTE prophylaxis. (1, ⊕⊕⊕o)
312101
In acutely ill hospitalized medical patients, the ASH guideline panel recommends inpatient VTE prophylaxis with LMWH only, rather than inpatient and extended-duration outpatient VTE prophylaxis with DOACs. (1, ⊕⊕⊕o)
Remark: If patients are on a DOAC for other reasons, this recommendation may not apply.
312101
Extended-duration outpatient prophylaxis vs inpatient-only prophylaxis
In acutely ill medical patients, the ASH guideline panel recommends inpatient over inpatient plus extended-duration outpatient VTE prophylaxis. (1, ⊕⊕⊕o)
312101
Extended-duration outpatient prophylaxis vs inpatient-only UFH or LMWH
In critically ill medical patients, the ASH guideline panel recommends inpatient over inpatient plus extended-duration outpatient VTE prophylaxis. (1, ⊕⊕⊕o)
312101
Chronically ill medical patients or nursing home patients
In chronically ill medical patients, including nursing home patients, the ASH guideline panel suggests not using VTE prophylaxis compared with using any VTE prophylaxis. (2, ⊕ooo)
Remark: If a patient’s status changes to acute, other recommendations would apply.
312101
Medical outpatients with minor provoking risk factors for VTE
In medical outpatients with minor provoking risk factors for VTE (eg, immobility, minor injury, illness, infection), the ASH guideline panel suggests not using VTE prophylaxis. (2, ⊕ooo)
312101
Long-distance travelers
In long-distance (>4 hours) travelers without risk factors for VTE, the ASH guideline panel suggests not using graduated compression stockings, LMWH, or aspirin for VTE prophylaxis. (2, ⊕ooo)
312101
In people who are at substantially increased VTE risk (eg, recent surgery, prior history of VTE, postpartum women, active malignancy, or ≥2 risk factors, including combinations of the above with hormone replacement therapy, obesity, or pregnancy), the ASH guideline panel suggests using graduated compression stockings or prophylactic LMWH for long-distance (>4 hours) travel. (2, ⊕ooo)
312101
In people who are at substantially increased VTE risk (eg, recent surgery, prior history of VTE, postpartum women, active malignancy, or ≥2 risk factors, including combinations of the above with hormone replacement therapy, obesity, or pregnancy), and in whom LMWH or graduated compression stockings is not feasible (eg, resource-constrained setting or aversion to other indicated anticoagulants), the ASH guideline panel suggests using aspirin rather than no VTE prophylaxis. (2, ⊕ooo)
312101
Recommendation Grading
Disclaimer
Overview
Title
Management of Venous Thromboembolism: Prophylaxis for Hospitalized and Non-Hospitalized Medical Patients
Authoring Organization
American Society of Hematology
Publication Month/Year
November 27, 2018
Document Type
Guideline
External Publication Status
Published
Country of Publication
US
Document Objectives
These evidence-based guidelines from the American Society of Hematology (ASH) intend to support patients, clinicians, and others in decisions about preventing VTE in these groups.
Target Patient Population
Acutely ill and critically ill medical inpatients, people in long-term care facilities, outpatients with minor injuries, and long-distance travelers.
Inclusion Criteria
Female, Male, Adolescent, Adult, Older adult
Health Care Settings
Emergency care, Hospital, Long term care
Intended Users
Nurse, nurse practitioner, physician, physician assistant
Scope
Prevention
Keywords
Venous Thromboembolism, VTE Prophylaxis
Source Citation
19 September 2018. DOI 10.1182/ bloodadvances.2018022954